Ganoderma is classified as a top grade traditional Chinese medicine for promoting human health by regulating 'vital energy'. Its potency towards metabolism and energy homeostasis, particularly, metabolic adaptations of adipocytes, needs to be re-evaluated through an evidence-based study. Here, the triterpenoid-rich Ganoderma tsugae ethanol extract (GTEE) was found to contribute towards adipogenesis accompanied with elevated intracellular lipid metabolic flux. Additionally, proteomic profiling revealed GTEE-upregulated mitochondrial remodeling and chemical energy redox modifications, which display UCP1-positive browning fat-selective features and a NADH-mediated adaptive mechanism. GTEE-treated mice with diet-induced obesity also resulted in the amelioration of white adipocyte hypertrophy and the appearance of UCP1-positive browning adipocytes. Our novel findings unravel that GTEE could promote intracellular metabolic flexibility and plasticity followed by the induction of adipocyte browning.
Ganoderma, also known as Lingzhi or Reishi, is a wellknown folk medicine in oriental countries and is used as a popular dietary supplement worldwide. It is classified as a top grade traditional Chinese medicine (TCM) and has gained considerable attention for its potential in promoting human health, regulating vital energy, and extending life span, as described in ancient TCM books. The bioactive components in Ganoderma have been identified to include polysaccharides, triterpenoids, proteins/peptides, nucleosides, alkaloids, and other trace elements [1] . These natural components from Ganoderma are associated with diverse pharmacological properties and have been applied to many medical purposes [2, 3] . However, few studies have elucidated the actual physiological metabolic health benefits, relevant mechanisms, and intriguing effects of Ganoderma, particularly on the issue of regulating vital energy. 'Vital energy' is a term described in the TCM books that implies potential metabolic-and energymediated effects.
Energy homeostasis is a key factor promoting metabolic health. Any imbalance between energy intake and expenditure would easily cause excessive energy being stored in the form of triglycerides (TG) in multiple sites of the body, mainly in adipose tissues, resulting in adipocyte hypertrophy followed by the development of obesity [4, 5] . Adipose tissue is viewed as a major organ that is responsible for lipid metabolism and that can respond toward external stimuli for metabolic adaptations depending on energy requirements and availability. Traditionally, mammals have two types of adipose tissues characterized by their macroscopic appearance: white adipose tissues (WAT) and brown adipose tissues (BAT). Each has its distinct morphological structures, physiological roles, and metabolic features [6] . Unilocular WAT is distributed throughout the body but often located in the abdominal/visceral (vWAT) and subcutaneous (sWAT) areas. WAT is not only a passive energy reservoir that stores excess energy as TG in a single large lipid droplet (LD) but also an active endocrine organ that exhibits extraordinarily high secretion of molecules termed adipokines. In comparison, multilocular BAT is located in specific depots, predominantly in the interscapular, cervical, paravertebral, and supraclavicular areas. BAT has an oxidative phenotype that is characterized by a high mitochondria content and uncoupling protein 1 (UCP1) expression, as well as elevated cellular respiration (i.e., oxidative phosphorylation, OXPHOS). BAT is also specialized in dissipating chemical energy to produce heat (i.e., nonshivering thermogenesis), protecting against hypothermia and excessive energy intake [7] . However, it is generally considered that the classical BAT in neonates prominently would gradually diminish and become indistinguishable from WAT with increasing age and, ultimately progressing toward nonexistent or nonfunctional in adult humans.
Accumulating evidence has identified a third type of adipocytes in rodents and adult humans, termed beige/ brown-like/brite (brown-in-white) adipocytes [8] [9] [10] [11] . Furthermore, it has been reported that, in humans, UCP1-expressing adipocytes could be either a beige or a brown adipocyte signature, depending on the location [12] . This type of cell interspersed within white fat depots resembles white adipocytes in the basal state, but it sporadically emerges as a browning or brownlike phenotype that is a metabolically adaptive in response to external stimuli. Examples of such triggers are cold exposure, b3-adrenergic stimulation or in response to peroxisome proliferator-activated receptor c (PPARc) ligand drug family Thiazolidinediones (TZDs). It also shares similar characteristics to classical BAT, including an increased number of mitochondria, increased levels of UCP1 expression and OXPHOS, and the formation of multilocular LDs [13] . This process is often referred to as 'browning' of adipocytes. Therefore, modulating the plasticity of adipocytes (i.e., stimulating browning) has been considered as an attractive strategy to increase excess energy dissipation and, ultimately, contribute to energy homeostasis [14] .
Energy expenditure relevant to obesity resistance could also be achieved through pharmacological and nutritional interventions that would increase mitochondrial biogenesis and oxidative capacity in WAT independent of UCP1 expression [15] . Induction of the lipid catabolism and the mitochondrial OXPHOS capacity is essential to achieve the metabolic flexibility of WAT so as to maintain energy homeostasis and to control the development of obesity. Therefore, new rational treatments could be tailored to improve the metabolic flexibility of WAT so as to increase lipid mobilization and mitochondrial OXPHOS capacity.
Because Ganoderma has being used for thousands of years to regulate 'vital energy' in a TCM context, its potency toward metabolism and energy homeostasis, particularly, adipogenesis (adipocyte differentiation), needs to be re-evaluated through a more scientific discourse. Several studies have reported that some isolated lanostane triterpenes from the fruiting bodies of Ganoderma lucidum (G. lucidum), Ganoderma applanatum (G. applanatum) mycelium extract containing active components (i.e., protocatechualdehyde), and standardized G. lucidum extracts (ReishiMax) containing triterpenes and polysaccharides showed inhibitory effects on adipogenesis, resulting in a decrease in lipid synthesis and accumulation [16] [17] [18] [19] [20] . However, one study also suggested that an induction in adipogenesis could also be achieved by an ethanol extract of a G. lucidum fruiting body containing approximately 10% of ganoderic acid A [21] . Despite these contradictory arguments, all studies had seemingly indicated that Ganoderma affects adipogenesis. Nevertheless, almost no study has committed to exploring the physiological effects of Ganoderma on metabolic flux and energy modulation during adipogenesis, particularly the metabolic adaptations of WAT.
In the present study, Ganoderma tsugae (G. tsugae), a well-known species of Ganoderma genus locally cultivated in Taiwan, was used for the first time to distinguish from the previous reports on G. lucidum and G. applanatum on adipogenesis. A proteomics approach was used to systematically describe the potential physiological effects of G. tsugae on the metabolic adaptations of adipocytes and the relevant molecular mechanisms. Such studies may be beneficial to provide significant molecular events in adipogenesis mediated by G. tsugae and may have tremendous contributions in utilization of valuable TCM resources and the development of nature-based antiobesity products.
Materials and methods

Preparation of Ganoderma tsugae extracts and identification of its bioactive ingredients
The powder of G. tsugae fruiting body was kindly provided by the Luo-Gui-Ying Fungi Agriculture Farm, Taoyuan, Taiwan. A quality-assured GTEE was prepared and the quality control was validated using both chemical fingerprint (HPLC and ESI-MS) and bioresponse fingerprint (PhytomicsQC comprehensive platform) analyses, as previously described [22, 23] . Isolation and identification of the bioactive ingredients contained in GTEE were performed by Tsuzuki Institute for Traditional Medicine, College of Pharmacy at China Medical University, Taichung, Taiwan. 
Cell culture and adipocyte differentiation
Cytotoxicity and viability assay
Ganoderma tsugae ethanol extract cytotoxicity on 3T3-L1 cells was assessed before, during, and after adipogenesis using the MTT assay, as previously described [24, 25] . 
Measurement of lipid content
At Day 12 of culture, which corresponded to differentiated adipocytes as described above, intracellular LD formation was observed using Oil red-O staining, as previously described [26] 
Measurement of lipolysis
Lipolysis assessment was performed by measuring the released free glycerol content as described previously [27] with slight modifications. Briefly, 3T3-L1 cells were induced to differentiate in the presence or absence of GTEE, and, at Day 12, the culture media were collected and the amount of glycerol was quantified with a Free Glycerol Colorimetric/Fluorometric Assay Kit (K630-100, BioVision, Inc.), according to the manufacturer's instructions. 
Two-dimensional gel electrophoresis
Analysis of gel images and protein identification
Analysis of gel images and in-gel digestion were performed as previously described [29] with slight modifications. Briefly, the differentially expressed spots among the three groups were matched and quantitatively analyzed with IMAGEMASTER 2D PLATINUM version 7.0 Software (GE Healthcare Life Sciences) following the user's manual. After a comparative analysis, the protein spots were excised from the polyacrylamide gels with tips and the gel pieces were destained by washing in wash buffer containing 10 mM ammonium bicarbonate and 50% acetonitrile for several times until no colors were observed. The pieces were then subjected to in-gel trypsin digestion (20 ngÁlL À1 trypsin) until analysis by mass spectrometry. The extracted peptides were redissolved in 0.1% formic acid buffer and spotted onto the MALDI target plate (0.5 lL) in triplicate followed by adding with 0. False discovery rate at peptide levels were determined based on a target decoy database within MASCOT software (significance threshold < 5%). Protein identifications were achieved based on probability-based target scores of Peptide Mass Fingerprints (PMF) and/or probability-based ion scores of MS/MS ion spectra of peptides. If the probability-based scores were equal to or greater than the Mascot Score significance level calculated for the search, the identification was considered to be statistically nonrandom at the 95% confidence interval (P < 0.05) [30] . The identified proteins, their functions and cellular locations were further subjected to be subcategorized based on the information provided by UniProt website (UniProtKB/Swiss-Prot database).
Western blotting
Protein samples from cells and tissues were subjected to western blot analysis as described previously [31] with slight modifications. Total proteins (50 lg) were loaded onto the SDS/PAGE gel, blotted onto the PVDF membrane, and subsequently hybridized with primary and corresponding HRP-conjugated secondary antibodies. The bands were visualized using the Enhanced Chemiluminescence System and quantified using the PHOTOSHOP software. Antibodies used in the study are listed in Table S1 .
Assessment of the NADH-to-NAD + ratio
3T3-L1 cells were induced to differentiate in the presence or absence of GTEE and the intracellular NADH/NAD + ratio was determined in the extract according to the manufacturer's instructions (NAD + /NADH Quantification Colorimetric Kit, K337-100, BioVision, Inc.).
Ethics statement and animal model
The procedures for the care and use of mice were approved and conducted in accordance with the guidelines from China Medical University (CMU), Taichung, Taiwan and was endorsed by the Institutional Animal Care and Use Committee (IACUC) of CMU (protocol No. 102-219-C). Male C57BL/6JNarl mice were purchased from the National Laboratory Animal Center, Taipei, Taiwan and fed a standard laboratory chow diet ad libitum for at least 1 week for acclimatization. Eight-week-old mice were divided into the following groups: standard chow diet (Prolab Ò RMH 2500 doses of GTEE (HFD/GTEE 150 group and HFD/GTEE 300 group). For the diet regimen during the feeding period of the experiments, the specific diets and distilled water were supplied ad libitum and GTEE were treated by oral gavage once per day for 12 weeks.
Morphological and histological analysis of adipose tissues
Tissue sections were prepared as described previously [32] with slight modifications. Briefly, fat-pad tissues from different regions were excised and fixed in a 10% neutral buffered formalin solution at 4°C until use. For the morphological analysis, fixed samples were dehydrated, paraffin-embedded, cut into 3-lm sections, and stained with hematoxylin and eosin (H&E) for microscopic examination (Pannoramic 250 FALSH II, 3DHISTECH Ltd.). The adipocyte size distribution was determined in three animals from each group using National Institutes of Health (NIH) IMAGEJ software. At least 1000 cells from each animal were measured from at least three independent tissue sections. Furthermore, the 3-lm tissue sections were also analyzed for HSP60 and UCP1 protein expressions by immunohistochemical staining. The HSP60-positive and UCP1-positive areas were photographed using a light microscope with a digital color camera (DM IL LED Fluo and DFC310FX, Leica Microsystems, Germany).
Glucose measurement and serological analysis
At the end of the feeding experiments, the mice were maintained under fed or fasted conditions. Blood specimens were collected and glucose concentrations were measured using a commercial glucose assay kit (GLUC-PAP Kit, GL 2623, Randox, Inc.), according to the manufacturer's instructions. For serological analysis, concentrations of triglycerides, total cholesterol, and LDL cholesterol were measured using assay kits from Roche with a Roche Cobas Mira Plus analyzer.
Statistical analysis
All data were expressed as the means AE SD from at least three individual experiments. Experimental differences between groups were compared using two-tailed unpaired Student's t test or one-way ANOVA test followed by Tukey's multiple comparison post hoc analysis with a 95% confidence interval. Statistical analyses were performed using SPSS statistical software (SPSS Statistics 17.0; Armonk, NY, USA) and differences were considered significant at P < 0.05.
Results
Analysis and identification of the bioactive ingredients contained in GTEE
The bioactive ingredients contained in GTEE were isolated and identified using HPLC, LC-MS/MS, and NMR techniques. Because triterpenes extracted from Ganoderma were reported to affect adipogenesis, ethyl acetate was added to partition the water insoluble fraction to obtain triterpenoids-rich GTEE (GTEE-EA C HMBC) NMR spectrum analysis and with subsequent comparison, the major peak (Compound 2) was identified as ganoderic acid C 2 (GAC-2) (3b, 7b, 15a-trihydroxy-11, 23-dioxo-5a-lanost-8-en-26-oic acid C 2 ) (Fig. S1 ). This was considered as one of the main ganoderic acids contained in GTEE-EA.
Low-dose GTEE induced adipogenesis accompanied with reduction in LD formation size in murine 3T3-L1 cells Previous reports on the potential physiological effects of Ganoderma extracts on adipogenesis were often inconsistent and controversial. Here, we investigated the cytotoxicity of GTEE and further evaluated the effects of GTEE on adipogenesis. At concentrations of up to 1 mgÁmL À1 and up to a 72 h incubation time, GTEE was shown to have no cytotoxic effects on 3T3-L1 fibroblasts (Fig. 1A) . However, high doses of GTEE (0.6-1 mgÁmL À1 ) would cause a significant time-dependent inhibition of 3T3-L1 cell viability during adipogenesis (Fig. 1B) . In differentiated, mature 3T3-L1 adipocytes, GTEE only at the dose of 1 mgÁmL À1 for 72 h was observed to significantly decrease cell viability by 45.03 AE 13.8% (Fig. 1C) . Hence, low-doses of GTEE (0.1-0.4 mgÁmL
À1
) were chosen for subsequent differentiation experiments.
3T3-L1 cells were treated with low-doses of GTEE from the initiation of differentiation to Day12 to assess the effects of GTEE on adipogenesis. The full PPARc agonist rosiglitazone (Rosi) was used as a positive control to stimulate complete adipogenesis [33] .
The extent of the adipogenesis and the development of the adipocyte phenotype were determined by Oil red-O staining. GTEE at the doses of 0.1 and 0.2 mgÁmL À1 , along with Rosi (2 lM) were found to significantly promote adipogenesis and LD accumulation compared to the IDI(+) and IDI(+)/Veh control groups. However, we noticed that at a dose of 0.4 mgÁmL À1 , GTEE did not significantly increase LD accumulation (Fig. 1D) . Notably, low doses of GTEE and Rosi contributed toward the formation of smaller LDs than compared to the differentiated 3T3-L1 adipocytes in the IDI(+) and IDI(+)/Veh groups, as shown by examination of the Oil red-O staining (Fig. 1E ). Similar to the positive effect of GTEE on adipogenesis, low dosage of GTEE-EA (0.05-0.2 mgÁmL À1 ) containing GAC-2, but not n-butanol and water-soluble partitions of GTEE, was also observed to have contributed toward adipogenesis with reduction in LD size formation (Fig. 1F,G) . Furthermore, we also studied the effects of G. tsugae water extract (GTWE) on 3T3-L1 cell viability and adipogenesis and did not observe any GTWE-mediated cytotoxic effect or the induction of adipogenesis, although we noticed a slight reduction in the size of the LDs (Fig. S2) . These results demonstrated that low-doses of GTEE containing GAC-2 would induce adipogenesis, accompanied by the reduction in LD formation size. This established in vitro model was used in the subsequent experiments to further identify the relevant effects and mechanisms by which GTEE would induce adipogenesis and the formation of small LDs.
GTEE improved the metabolic flux and status of murine 3T3-L1 adipocytes by elevating lipid catabolism
Based on the positive effect of GTEE on adipogenesis and changes in LD formation size, we speculated that ), and morphological changes were photographed at 20X objective. All values were shown as the means AE SD from at least three independent experiments. *P < 0.05 versus vehicle control. Mean values without a common letter (i.e., a, b, c, and d) were significantly different among groups (P < 0.05).
GTEE could potentially be involved in lipid mobilization during adipocyte formation. Therefore, we decided to investigate the effects of GTEE on lipid synthesis, fusion, and breakdown. As anticipated from Fig. 1D , after individually treating 3T3-L1 cells with vehicle, GTEE and Rosi, the relevant proteins involved in adipogenesis, lipid synthesis, and LD formation seemed to be upregulated from Day 0 to Day 12. These proteins included PPARc 2 , fatty acid synthase (FAS), fatty acid binding protein 4 (FABP4, also called adipocyte Protein 2, aP2), and perilipin 1 (PLIN1) (Fig. 2A) . Furthermore, TG content was found to be increased significantly by GTEE and Rosi (Fig. 2B ) that was consistent with the Oil red-O staining results shown in Fig. 1D . Interestingly, we found the GTEE treatment downregulated the expression of fat-specific protein 27 (FSP27, also called CIDEC), a key protein that regulates LD clustering, fusion, and growth in adipocytes ( Fig. 2A and E) . Subsequently, we examined whether GTEE would exert pro-lipolytic activity during adipogenesis. The levels of released glycerol, released glycerol/intracellular TG, and LDassociated key enzymes involved in TG hydrolysis, including adipose triglyceride lipase (ATGL) and Serine 563 phosphorylation of hormone-sensitive lipase (HSL), were also significantly increased by GTEE (Fig. 2C-E) . The lipolytic activity of HSL is primarily controlled by Serine 563 phosphorylation site [34] . In addition, diacylglycerol O-acyltransferase 1 (DGAT1), a key enzyme that catalyzes the terminal and only committed step in TG synthesis, was downregulated by GTEE (Fig. 2E) . Collectively, these results suggested that GTEE could induce 3T3-L1 cell adipogenesis accompanied with elevation of lipid mobilization, including decreased LD fusion processes and increased pro-lipolytic activities, and promote cellular metabolic flux and flexibility.
Proteomics analysis of differentially expressed proteins during GTEE-induced adipogenesis
To understand the detailed mechanisms underlying the GTEE-induced changes during adipogenesis, proteomics was used to identify the differentially expressed proteins in cells treated with or without GTEE. Whole cell protein lysates were prepared from the following three groups after 12 days differentiation: IDI(+)/Veh, IDI(+)/GTEE 0.2, and IDI(+)/ Rosi. Lysates were separated by 2-DGE and differentially expressed proteins were visualized by blue silver staining (Fig. 3A) . There were 475 AE 103 spots on the IDI(+)/Veh gel, 561 AE 122 spots on the IDI(+)/ GTEE 0.2 gel, and 437 AE 96 spots on the IDI(+)/ Rosi gel based on the IMAGEMASTER Software analysis. Comparative analysis of the proteome maps from the three groups (at least two representative gels per group) were performed with automated spot detection and auto-matching using software analysis, followed by auto-matched visible spots selection manually in accordance with the locations of landmarkers on each gel (Fig. S3A) . In addition, these visible auto-matched spots, whose expression levels were upregulated by GTEE (relative to the vehicle group), were also observed in the third gel analysis of independent replicate (Fig. S3B) . The imaging analysis showed that at least 30 matched spots were upregulated by GTEE (Fig. 3B and Table S2 ). Among the differentially expressed protein spots, 10 proteins were found to be upregulated by both GTEE and Rosi, while only eight proteins were only upregulated by GTEE (by a factor of ≧ 1.5-fold in each group compared to the Veh group) ( Table 1 ). In addition, 12 proteins were upregulated by GTEE compared with the Rosi group (by a factor of ≧ 1.5-fold in the GTEE group) ( Table 2 ). The representative spots corresponding to cytochrome b-c1 complex subunit 1 (spot No. 151: QCR1, mitochondrial) and pyruvate dehydrogenase E1 component subunit beta (spot No. 91: ODPB, mitochondrial) were highlighted in order to show the reproducibility of the observed expressed proteins between IDI(+)/GTEE 0.2 and IDI(+)/Rosi groups (Fig. 3C) . Peptide sequences used for protein identification were listed in Table S3 . The raw gel images and mass spectrometry data associated with this manuscript could be found from the figshare repository using the DOI number https://doi. org/10.6084/m9.figshare.5872149. These identified proteins, their expression status, physical features, and functions were subsequently subcategorized and investigated. Identification and validation of the GTEE-induced differentially expressed proteins revealed involvement in oxidative metabolism, redox modifications, and mitochondrial biogenesis
Based on the biological functions and cellular locations of the 30 identified proteins differentially upregulated by GTEE (Tables 3 and 4) , approximately 65% (19/30) are primarily involved in oxidative metabolism, including intracellular catabolism processes, tricarboxylic acid (TCA) cycle, and electron transport chain (ETC). Protein folding (chaperones), protein biosynthesis, other metabolic processes, cytoskeleton-based processes, and other related proteins each comprised approximately 3-13% of the total identified proteins (Fig. 4A) . Cellular location analyses also revealed that 54% (16/30) proteins were mitochondrial proteins Proteins (400 lg) from cells were separated on a 2-DGE using 17-cm pH 5-8 IPG strips in the first dimension and 12% SDS/ PAGE gels in the second dimension and then stained with blue silver reagent for visualization of protein spots. The numbers on the left of the gel indicate the approximate molecular mass (kDa) determined using Bio-Rad protein markers. Three spots as land markers were indicated with white arrows. (B) The 30 spots with an altered intensity in GTEE-induced adipocyte proteome profile compared to vehicle control and Rosi groups were circled and the matched numbers corresponded to the spot numbers in Tables 1 and 2 . Representative gels of all independent replicates, including the three gels shown above in (A), used for comparative analysis of the expressed protein profiles were presented in involved in mitochondrial biogenesis, oxidative metabolism, and redox modifications (Fig. 4B) (Fig. 4C) .
As the proteomic study revealed that many proteins involved in mitochondrial biogenesis, catabolism processes, TCA cycle, and ETC were upregulated during GTEE-induced adipogenesis, we hypothesized that GTEE would stimulate the adipocyte browning. Recent evidence showed that the browning of white adipocytes, characterized by Ucp1 expression and the oxidative phenotype with mitochondria, was induced and controlled by the intracellular metabolic intermediate lactate (isoform B of the lactate dehydrogenase, LDHB), which mediates cellular redox modifications, namely NAD + ? NADH + H + [35] . Hence, we investigated the effects of GTEE on several browning fat-selective and mitochondrial-related marker proteins, including UCP1, CIDEA, HSP60, and cytochrome c, as well as the cellular redox state (i.e., the NADH/NAD + ratio). Western blotting and NAD + /NADH quantitation assays were also served to validate the proteomic profiles. Strikingly, prolonged treatment with GTEE upregulated the levels of UCP1, CIDEA, HSP60, and cytochrome c proteins during 3T3-L1 adipogenesis (Fig. 4D, left and right panels) . The NADH/NAD + ratio and the NADH content were also significantly increased after treatment with 0.2 mgÁmL À1 GTEE (Fig. 4E) . These results further reinforce the notion of GTEE-mediated improvements in the metabolic flexibility and plasticity of adipocytes, displaying the browning features in adipocytes. The full PPARc agonist Rosi treatment, which was reported to induce mitochondrial biogenesis and remodeling, as well as oxidative capacity in adipocytes [36] [37] [38] , also exhibited similar effects on browning features. Here, GTEE was found to have more positive effects on browning fatselective features than that of Rosi. Based on a previous study proposing that AMPactivated protein kinase (AMPK) was induced by G. lucidum extracts (ReishiMax) (reference 19) and the finding of GTEE-induced modifications in the NADH/ NAD + ratio in our study, we also evaluated whether GTEE would affect intracellular energy sensor proteins, including AMPK and sirtuin 1 (SIRT1). We found that low-doses of GTEE would upregulated the levels of SIRT1 protein and the Threonine 172 phosphorylation of AMPK during 3T3-L1 adipogenesis (Fig. 4D, left panel) . Collectively, these results suggested that GTEE could mediate intracellular energy requirements and availability and promoted cellular metabolic flexibility and plasticity, subsequently followed by the induction of UCP1-positive brown-like adipogenic program via a reported adaptive mechanism of chemical energy redox modifications (NADH/ NAD + ).
GTEE induced adipose cell browning and prevented diet-induced obesity
Since GTEE induced browning fat-selective features and brown-like adipogenic program in vitro in the 3T3-L1 cell model, we further examined whether GTEE could also induce adipocyte browning in vivo and helped animals resist diet-induced obesity (DIO). To test the hypothesis, the standard chow diet (SCD) was replaced with a high-fat diet (HFD, 60% calories from fat) immediately after mice were randomly assigned to groups treated with vehicle control or GTEE. In order to obtain insights into the impact of GTEE on the WAT mitochondria, immunohistochemical staining of the major WAT fat-pad depots was performed using mitochondrial HSP60 and UCP1 antibodies. Strikingly, for all observed WAT depots, the number of HSP60-positive mitochondria in the GTEE-treated mice was greater than that of the HFD control mice, indicating that GTEE stimulated mitochondrial biogenesis in white fat during the development of obesity (Fig. 5A) . Compared with the HSP60 positivity in the same white fat-pad tissue sections, GTEE-induced UCP1 positivity was highly expressed in the inguinal WAT (Ing WAT) and perirenal WAT (PR WAT) but low in the epididymal WAT (Epi WAT) (Fig. 5B) . Interscapular BAT (iBAT) was chosen as a positive control for assessing browning features in WAT. Representative micrographs of the inguinal and perirenal depots showed that the GTEEtreatment increased UCP1 positivity not only in the peripheral cytoplasm of unilocular adipocytes (positive paucilocular cells) but also in the inducing smaller multilocular fat cells (Fig. 5B,C) . Furthermore, using western blotting and real-time PCR, it also showed that GTEE could upregulate UCP1 and HSP60 expression of inguinal depots (Fig. S4 ). In addition, we observed both p-AMPKa and AMPKa levels, but not SIRT1, in inguinal depots seemed to be upregulated by GTEE, (Fig. S5) . These phenomena might be caused by individual mouse difference, heterogeneous mixture of different cells in WAT, or complex energy metabolism effects. Collectively, these results suggested that GTEE promoted browning fat features and stimulated the appearance of brown-like adipocytes interspersed throughout the WAT of mice fed with the HFD. Finally, GTEE-treated mice were found to have gained less weight than the HFD control mice with equal food intake (Fig. S6) and exhibited less susceptibility toward DIO, with unchanged organ weights and a slight reduction in the major fat-pad weights (Fig. 6A,B) . Furthermore, GTEE-treated mice had comparatively smaller white adipocytes than the HFD control groups in areas including Epi WAT, Ing WAT, and PR WAT (Fig. 6C) . Adipocytes in the visceral depot (Epi WAT) were significantly smaller in GTEE-treated mice (Fig. 6C,D) . GTEE also decreased LD fusion and growth in iBAT (Fig. 6C) . These findings were consistent with the results from the cultured cells shown in Fig. 1E and 2E (FSP27) in that GTEE reduced LD fusion and growth, resulting in an amelioration of adipocyte hypertrophy. Furthermore, GTEE not only maintained glucose in a lower level but also prevented DIO-associated dyslipidemia (Fig. 7) . These results were consistent with the findings in cultured cells and proteomic profiling studies. It clearly indicated that GTEE promoted cellular metabolic flexibility and plasticity, and stimulated adipocyte hypertrophy amelioration and adipocyte browning in WAT in vivo, leading to partial resistance to DIO.
Discussion
The concepts of regulating 'vital energy' and of slowing the aging process, as described in TCM text, has been associated with preserving the structural and functional integrity of mitochondria [39] . The present study showed, for the first time, that a triterpenoidsrich GTEE would promote metabolic flexibility and plasticity followed by displaying UCP1-positive browning features in white adipocytes through a reported adaptive mechanism of intracellular mitochondrial remodeling and chemical energy redox modifications (NADH/NAD + ) (Fig. 8) . Through re-evaluation of the role and underlying mechanisms of Chinese medicines at the proteomic level of analysis, our novel findings may provide a new and rational physiological mechanism by which Ganoderma promotes metabolic processes and regulates 'vital energy'. The extent by which GTEE affected adipogenesis was found to be dependent on its concentration. In this study, GTEE at concentrations up to 0.4 mgÁmL À1 did not affect the viability of 3T3-L1 cells either in the preadipocyte state or throughout the differentiation process, while significantly contributing toward adipogenesis of 3T3-L1 cells (especially at GTEE doses of 0.1-0.2 mgÁmL
À1
) with reduction in LD formation size. Interestingly, although high doses of GTEE (0.6-1.0 mgÁmL À1 ) were not cytotoxic and did not inhibit the proliferation of 3T3-L1 in the preadipocyte state, they caused a time-dependent inhibition of cell viability during the differentiation process and in differentiated mature 3T3-L1 adipocytes (Fig. 1) . Murine embryonic 3T3-L1 fibroblast is a well-established in vitro model for white adipogenic differentiation to mimic physiological phenotypic changes occurring in fat cells, such as the defined features of dynamic changes in LD formation size and mitochondrial biogenesis in vitro [40] [41] [42] [43] . Our results demonstrated that GTEE exerted multiple effects on adipogenesis, including the induction of potential noncanonical adipogenesis by low doses of GTEE and the reduction in WAT-like adipocyte formation and the number of mature adipocytes by high doses of Distribution and average of adipocyte size in epididymal WAT from mice fed with experimental diets for 12 weeks were analyzed. The white, black, dark gray, and light gray bars represented the SCD group, HFD group, vehicle-treated group, and GTEE-treated groups respectively. All values were shown as the means AE SD (n = 3-5 animals/group). Mean values without a common letter (i.e., a, b, and c) were significantly different among groups (P < 0.05).
GTEE. Thus, a crude extract from the same mushroom may have different activities in adipogenesis depending on different concentrations, but their relevance requires further study.
The mechanism by which GTEE reduced LD formation size during adipogenesis was found to be associated with lipid mobilization. Here, low-dose GTEE was found to not only induce complete adipogenesis, as characterized by TG accumulation and the upregulation of relevant marker proteins, but also elevate prolipolytic activity, as characterized by glycerol release and the upregulation of LD-associated lipolytic enzymes. Furthermore, GTEE treatment resulted in reduced LD fusion and growth, along with the downregulation of FSP27 (Fig. 2) . LD formation within adipocytes are determined by both the levels of LDassociated proteins and interactions between relevant proteins that are constitutively localized on the LD surface, such as PLIN1, FSP27, ATGL, and HSL, as previously reviewed [44, 45] . PLIN1 is mainly expressed in adipose tissues and restricted to LDs and thus important for the stabilization of LDs and the control of lipolysis [46] . PLIN1 can promote unilocular LD formation through the activation of FSP27 and regulate hormone-stimulated lipolysis [47, 48] . FSP27 is essential for the formation of unilocular LDs from small/micro LDs during adipogenesis, and mediates LDs coarsening and remodeling in adipocytes [49, 50] . Well-characterized neutral lipolysis requires three consecutive steps and three major enzymes -ATGL, HSL, and MGL -to yield glycerol and fatty acids. In adipose tissues, both of ATGL and HSL are localized to LDs and are primarily responsible for coordinating 90% of TG hydrolysis [51] . In addition, ATGLmediated lipolysis is also required for PPAR signaling and even normal mitochondrial function and OXPHOS [52] . Our results showed that GTEE promoted cellular metabolic flux and flexibility, leading to the activation of noncanonical adipogenesis with elevation of lipid catabolism. In comparison with Rosi, GTEE has similar, but more positive effects on adipogenesis and lipid catabolism. It has been reported that Rosi has the ability to concomitantly promote complete adipogenesis and induce the transcriptional levels of ATGL and HSL, even activating the browning of white adipose tissues [53] [54] [55] . Collectively, our findings propose for the first time that GTEE could decrease LD formation size and promote lipid mobilization during adipogenesis and imply potential activities for Ganoderma-mediated lipid metabolic flux in adipose tissues.
Two key approaches were used in this study to unravel the global effects of GTEE on adipogenesis, a comprehensive proteomics technique and a well-established in vitro 3T3-L1 cell model. Based on these two methods, we had identified clusters of proteins involved in oxidative metabolic pathways and chemical energy metabolism (i.e., NADH/NAD + ) within mitochondria that were upregulated by GTEE compared with the vehicle-only control and the positive-control (i.e., Rosi treatment) groups (Fig. 3 , Tables 1 and 2 ). Strikingly, the expression levels of UCP1, CIDEA, and HSP60 -which are only highly expressed in classical BAT -and the NADH/NAD + Fig. 8 . Schematic representation of the metabolic pathways and redox modifications that occur in GTEE-induced adipocyte browning. Upregulated proteins and chemical energy (black) and downregulated proteins (gray) involved in oxidative metabolism (glycolysis, lipid catabolism, b-oxidation, amino acid degradation, TCA cycle, and ETC.) were highlighted. We proposed that browning of adipocyte differentiation induced by GTEE constitutes an adaptive mechanism to alleviate redox pressure.
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FEBS Letters 592 (2018) 1643-1666 ª 2018 Federation of European Biochemical Societies ratio were upregulated by GTEE, suggesting that GTEE activated mitochondrial remodeling, oxidative metabolism, and redox modifications during adipogenesis (Fig. 4, Tables 3 and 4) . Such orchestrated changes in the expression of multiple proteins identified in our proteomic profiles are in agreement with the results at the transcript and proteome levels of a previous study [56] . It determined that the mitochondria in BAT are predominantly involved in the TCA cycle and OXPHOS, whereas the mitochondria in WAT are characterized by anabolic functions. These results provided insights into the mechanism underlying that GTEE-mediated higher redox environment within the mitochondria of preadipocytes is ready permissive toward the induction of brown-like adipocyte differentiation. Indeed, as shown in research by Carriere et al. (reference 35), stimulating an increase in the intracellular NADH/NAD + redox state by intermediate metabolites promoted the induction of browning of WAT, as characterized by Ucp1 expression. The browning process was considered an adaptive mechanism to alleviate redox pressure. Furthermore, accumulating evidence have suggested that the induction of the molecular events that orchestrate adipocyte differentiation, metabolism, and even the efficiency of mitochondrial metabolism are driven by changes in the intracellular redox state, such as physiological NADPH oxidase-induced reactive oxygen species (ROS) and glutathione (GSH) redox state [57] [58] [59] [60] . In addition, a previous study reported that adipocyte differentiation may be enhanced under conditions promoting intracellular and mitochondrial compartment oxidation [61] . Collectively, these findings should favor GTEE as an external stimulus to promote intracellular redox state and metabolic adaptations (i.e., an oxidative phenotype within mitochondria) in preadipocytes, followed by the induction of browning of adipocyte differentiation to alleviate redox pressure.
It is known that mitochondrial biogenesis and remodeling are inherent to adipose differentiation per se and occur in response to the external stimuli [62] . Furthermore, under appropriate stimulation, the plasticity modification, such as phenotype switch, of the anatomy of the adipose tissues in adult animals was also documented [63, 64] . The possibility of a white-tobrown adipocyte conversion due to the elevated mitochondrial capacity and energy expenditure characteristics, as well as obesity resistance is of special medical interests. Herein, we have demonstrated that GTEE induced mitochondrial remodeling and UCP1-positive browning features in adipocytes in vitro and in vivo (Figs 4 and 5) . All the in vivo data are consistent with our in vitro findings, indicating that as a pharmacological and dietary stimulus, GTEE could promote adipocyte hypertrophy amelioration and adipocyte browning in WAT and further prevent DIO and associated progressive metabolic dysfunctions (Figs 6 and 7). Browning of adipose tissue is an adaptive and reversible response to environmental challenges [65] . However, the origin and development of these inducible UCP1-positive brown-like adipocytes distinct from those of classical BAT are still unclear. There are three potential processes to explain that these UCP1-positive brown-like adipocytes appear to be derived from (a) the defined beige precursors, (b) directed differentiation from white precursors, or (c) transdifferentiation from differentiated white adipocytes, as previously reviewed [66] . Actually, Ohno et al. (reference 55) showed that chronic treatment with the Rosi could promote all preadipocytes isolated from the stromal vascular fraction of subcutaneous WAT to express beige cell markers, including ucp1 and cidea, indicating that cellular plasticity between white and brown-like adipocyte might exist at the precursor stage. The previous study, along with our findings, clearly suggested that it should be plausible that browning of UCP1-positive white adipocytes and mitochondrial remodeling processes could occur during adipogenesis.
It is essential to know the bioactive ingredients from GTEE involved in the adipocyte browning process. We have identified that GAC-2 is one of the main ganoderic acids contained in GTEE-EA. Furthermore, GTEE-EA was also found to exhibit similar positive effect on adipogenesis comparative to GTEE. Interestingly, a previous study has reported that G. lucidum containing GAC-2 could enhance mitochondrial biogenesis and attenuate mitochondrial defects in nerve growth factor (NGF)-responsible PC12 cells to show the neuroprotective effects [67] . That study complements with our current finding and implies that GAC-2 contained in Ganoderma may be one potential bioactive ingredient involved in mitochondrial integrity. However, the role of GAC-2 in the mitochondrial integrity and browning adipocyte induction needs to be further investigated.
In conclusion, the present study highlights the physiological effects of and molecular events during adipogenesis triggered by GTEE at the proteomic level of analysis and reveals that GTEE can act as an external stimulus to promote intracellular metabolic flexibility and plasticity followed by displaying browning features in white adipocytes. This study also provides some scientific basis for the origins of 'vital energy' regulation by Ganoderma and its association with metabolic and energy homeostasis, and may shed new light on the strategy for preventing obesity.
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